GET DAILY SIGNALSeHealth (EHTH) Q3 2026: Revenue Falls 60% but Cash Flow Shows Improvement
Key Takeaways
- eHealth, Inc. (EHTH) reported third quarter 2026 revenue of $21.3 million, a 60% decline from $53.9 million a year earlier and below the consensus estimate near $26–27 million.
- GAAP net loss attributable to common stockholders was $1.57 per share, wider than the analyst estimate of roughly a $1.12 loss per share.
- Adjusted EBITDA came in at negative $39.9 million, compared with negative $34.0 million in the prior-year period.
- Operating cash flow improved to negative $11.2 million from negative $25.3 million, a $14.1 million year-over-year gain reflecting the company's cost-reduction push.
- Management reaffirmed its full-year 2026 guidance ranges and modestly raised its 2026 net adjustment revenue outlook.
- Additional details on major news, today's price action, price targets, and forecasts are available on dedicated pages.
Earnings Context and Why It Matters
eHealth, Inc. (EHTH) runs a leading private online health insurance marketplace that connects consumers with Medicare and other coverage options. Its third quarter results, reported on November 4, 2026, come during a prolonged Medicare Advantage reset cycle in which carriers are focusing on profitability rather than enrollment growth. The company is intentionally reducing marketing spend, concentrating investment in high-return periods, and moving toward a "lifetime advisory" model to build deeper member relationships and cross-sell opportunities. This report is important because it indicates whether those strategic shifts are improving unit economics and cash flow, even as top-line revenue contracts sharply. Investors are watching closely to see whether cost reductions and enrollment quality gains can offset the steep decline in applications and commission revenue. I also checked this using Tickeron’s AI Screener to see how EHTH compares to peers in the sector.
Reported Results
For the third quarter ended September 30, 2026, eHealth reported total revenue of $21.3 million, down 60% from $53.9 million in the prior-year period and below the analyst consensus estimate of approximately $26.4 million. Commission revenue fell 62% to $17.8 million.
GAAP net loss was $35.9 million, compared with a net loss of $31.7 million a year ago. The net loss attributable to common stockholders was $50.4 million, or $1.57 per basic and diluted share, versus the roughly $1.12 per share loss analysts had expected. Adjusted EBITDA was negative $39.9 million, compared with negative $34.0 million in the prior-year quarter.
Within the Medicare segment, revenue declined 64% to $18.1 million, driven by lower enrollment volume and a sharp drop in "tail" revenue to $1.5 million from $12.1 million. The Employer and Individual segment generated revenue of $3.2 million, down from $3.9 million. Total operating costs and expenses fell 29% to $67.6 million, with marketing and advertising expense down 55%.
Operating cash flow was negative $11.2 million, a 56% improvement from negative $25.3 million a year earlier. The company ended the quarter with $88.1 million in cash, cash equivalents, and short-term marketable securities, and a commissions receivable balance of roughly $970 million, up about 7% year over year. Management reaffirmed its fiscal 2026 guidance ranges and updated its 2026 net adjustment revenue expectation to $17 million–$20 million, up from $16 million–$20 million. From what I see, the cash flow progress stands out as a positive signal amid the revenue pressure.
Market Reaction and Investor Sentiment
EHTH shares closed at $0.64 ahead of the report and slipped roughly 4% in after-hours trading to about $0.61 following the earnings release. The stock has declined approximately 87% year to date, reflecting persistent investor concern over the shrinking revenue base and the extended Medicare Advantage reset cycle. While the company emphasized that results were in line with its internal expectations and highlighted a meaningful improvement in operating cash flow, the top-line miss and a wider-than-expected per-share loss weighed on sentiment. Investor focus is likely to shift toward the upcoming annual enrollment period, when the company concentrates much of its marketing spend and expects higher-return enrollment activity.
Forward Outlook and Key Factors to Monitor
Looking ahead, investors should monitor several factors tied to eHealth's strategic repositioning. The company has reaffirmed its fiscal 2026 guidance, signaling confidence that cost reductions and disciplined demand generation remain on track. Management reiterated longer-term goals of returning to mid-single-digit revenue growth in 2027, accompanied by expanded adjusted EBITDA margins and positive operating cash flow.
The most important near-term catalyst is the fourth-quarter annual enrollment period, when eHealth concentrates its marketing investment and typically generates the bulk of its Medicare enrollments. Carrier decisions on benefits, service areas, and commission levels will directly influence both application volume and the economics of each enrollment.
Investors should also track the lifetime advisory model's progress. Early indicators, including an ancillary cross-sell rate above 40% in the third quarter, suggest the strategy is building momentum, but the financial payoff is expected to materialize gradually through 2027 and 2028. Cash flow generation, commission receivable trends, and the pace of "tail" revenue recognition remain important signals of the quality and durability of the company's book of business. I'm watching this closely as the annual enrollment period approaches.
Exploring AI Tools for Stock Research
In my own analysis, I often turn to Tickeron’s AI Screener when evaluating names like EHTH. This AI-powered tool lets me filter stocks by technical patterns, fundamentals, and performance metrics in one place, helping surface ideas and monitor market shifts more efficiently than manual methods. It has become a practical part of my routine for tracking companies in dynamic sectors like insurance and healthcare.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Contributor
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
EHTH sees its Stochastic Oscillator ascends from oversold territory
On November 03, 2026, the Stochastic Oscillator for EHTH moved out of oversold territory and this could be a bullish sign for the stock. Traders may want to buy the stock or buy call options. Tickeron's A.I.dvisor looked at 60 instances where the indicator left the oversold zone. In 49 of the 60 cases the stock moved higher in the following days. This puts the odds of a move higher at over 82%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where EHTH's RSI Oscillator exited the oversold zone, 32 of 45 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 71%.
The Momentum Indicator moved above the 0 level on November 03, 2026. You may want to consider a long position or call options on EHTH as a result. In 69 of 90 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 77%.
The Moving Average Convergence Divergence (MACD) for EHTH just turned positive on October 06, 2026. Looking at past instances where EHTH's MACD turned positive, the stock continued to rise in 31 of 45 cases over the following month. The odds of a continued upward trend are 69%.
Following a +25.71% 3-day Advance, the price is estimated to grow further. Considering data from situations where EHTH advanced for three days, in 172 of 224 cases, the price rose further within the following month. The odds of a continued upward trend are 77%.
Bearish Trend Analysis
Following a 3-day decline, the stock is projected to fall further. Considering past instances where EHTH declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 88%.
EHTH broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for EHTH entered a downward trend on November 04, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 12 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.038) is normal, around the industry mean (2.680). P/E Ratio (-0.803) is within average values for comparable stocks, (19.297). Projected Growth (PEG Ratio) (0.030) is also within normal values, averaging (8.322). Dividend Yield (0.000) settles around the average of (0.039) among similar stocks. P/S Ratio (0.053) is also within normal values, averaging (2.968).
The Tickeron Seasonality Score of 75 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is 90 (best 1 - 100 worst), indicating slightly worse than average price growth. EHTH’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 92 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 97 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. EHTH’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 84, placing this stock worse than average.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
a provider of health insurance services
Industry InsuranceBrokersServices
Advertisement